Sherbrooke Park Advisers LLC Nevro Corp Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Nevro Corp stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 36,612 shares of NVRO stock, worth $209,786. This represents 0.04% of its overall portfolio holdings.
Number of Shares
36,612Holding current value
$209,786% of portfolio
0.04%Shares
2 transactions
Others Institutions Holding NVRO
# of Institutions
145Shares Held
37.6MCall Options Held
622KPut Options Held
1.39M-
Arrow Mark Colorado Holdings LLC Denver, CO4.36MShares$25 Million0.24% of portfolio
-
Armistice Capital, LLC New York, NY3.74MShares$21.4 Million0.2% of portfolio
-
Black Rock Inc. New York, NY3.6MShares$20.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$11.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.8MShares$10.3 Million0.01% of portfolio
About NEVRO CORP
- Ticker NVRO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 35,387,800
- Market Cap $203M
- Description
- Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...